Andrew Duncombe

4.3k total citations · 1 hit paper
35 papers, 2.0k citations indexed

About

Andrew Duncombe is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Andrew Duncombe has authored 35 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 19 papers in Hematology and 15 papers in Molecular Biology. Recurrent topics in Andrew Duncombe's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Andrew Duncombe is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (16 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Acute Myeloid Leukemia Research (8 papers). Andrew Duncombe collaborates with scholars based in United Kingdom, United States and Australia. Andrew Duncombe's co-authors include Nicholas C.P. Cross, Joannah Score, Thomas Ernst, Claire Hidalgo-Curtis, Amy V. Jones, Katerina Zoi, Andreas Reiter, Francisco Cervantes, David Oscier and Andreas Hochhaus and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Andrew Duncombe

32 papers receiving 2.0k citations

Hit Papers

Inactivating mutations of the histone methyltransferase g... 2010 2026 2015 2020 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Duncombe United Kingdom 18 1.2k 1.1k 915 284 187 35 2.0k
Hadrian Szpurka United States 17 939 0.8× 1.4k 1.3× 972 1.1× 206 0.7× 128 0.7× 35 2.0k
Stephen E. Langabeer Ireland 20 1.3k 1.1× 2.3k 2.0× 959 1.0× 214 0.8× 584 3.1× 104 2.7k
Roberta La Starza Italy 24 796 0.7× 976 0.9× 370 0.4× 239 0.8× 460 2.5× 91 1.8k
Jean-Luc Laı̈ France 14 605 0.5× 1.1k 1.0× 715 0.8× 297 1.0× 168 0.9× 33 1.4k
Brenton G. Mar United States 16 982 0.8× 1.5k 1.4× 667 0.7× 103 0.4× 279 1.5× 33 2.3k
Giovanna Rege‐Cambrin Italy 21 612 0.5× 1.4k 1.3× 893 1.0× 352 1.2× 669 3.6× 70 2.0k
Nathalie Grardel France 15 322 0.3× 848 0.8× 591 0.6× 250 0.9× 281 1.5× 40 1.3k
M Malec Sweden 5 722 0.6× 1.6k 1.5× 592 0.6× 261 0.9× 888 4.7× 7 2.1k
Lukasz P. Gondek United States 22 773 0.6× 1.6k 1.4× 701 0.8× 73 0.3× 226 1.2× 90 2.0k
JM Cayuela France 19 519 0.4× 887 0.8× 348 0.4× 173 0.6× 420 2.2× 24 1.4k

Countries citing papers authored by Andrew Duncombe

Since Specialization
Citations

This map shows the geographic impact of Andrew Duncombe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Duncombe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Duncombe more than expected).

Fields of papers citing papers by Andrew Duncombe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Duncombe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Duncombe. The network helps show where Andrew Duncombe may publish in the future.

Co-authorship network of co-authors of Andrew Duncombe

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Duncombe. A scholar is included among the top collaborators of Andrew Duncombe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Duncombe. Andrew Duncombe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duncombe, Andrew, Mary Frances McMullin, Ruben A. Mesa, et al.. (2023). The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden. SHILAP Revista de lepidopterología. 4(4). 1071–1080. 1 indexed citations
4.
Lewis, Dana, et al.. (2022). Glioblastoma, IDH-wildtype: A New Association with IgM Paraproteinaemic Neuropathy?. SHILAP Revista de lepidopterología. 14(1). 213–222. 2 indexed citations
5.
Ardern‐Jones, Michael R., Hang Phan, Florina Borca, et al.. (2021). Secondary haemophagocytic lymphohistiocytosis in hospitalised COVID-19 patients as indicated by a modified HScore is infrequent and high scores do not associate with increased mortality. Clinical Medicine. 21(5). e543–e547. 4 indexed citations
6.
Howard, Dena, Talha Munir, Lucy McParland, et al.. (2017). Results of the randomized phase IIB ARCTIC trial of low-dose rituximab in previously untreated CLL. Leukemia. 31(11). 2416–2425. 21 indexed citations
7.
Butt, Nauman M., Jonathan Lambert, Sahra Ali, et al.. (2017). Guideline for the investigation and management of eosinophilia. British Journal of Haematology. 176(4). 553–572. 83 indexed citations
9.
Larráyoz, Marta, Stuart J. Blakemore, Rachel Dobson, et al.. (2015). The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1. Leukemia. 30(2). 351–360. 83 indexed citations
10.
McMullin, Mary Frances, Glen James, Andrew Duncombe, et al.. (2015). Patient perspectives of a diagnosis of myeloproliferative neoplasm in a case control study. Experimental Hematology and Oncology. 5(1). 14–14. 3 indexed citations
11.
Anderson, Lesley, Glen James, Andrew Duncombe, et al.. (2015). Myeloproliferative neoplasm patient symptom burden and quality of life: Evidence of significant impairment compared to controls. American Journal of Hematology. 90(10). 864–870. 33 indexed citations
12.
Duncombe, Andrew, Mary Frances McMullin, Michael O’Rorke, et al.. (2014). How common are myeloproliferative neoplasms? A systematic review and meta‐analysis. American Journal of Hematology. 89(6). 581–587. 148 indexed citations
13.
Reilly, John T., Mary Frances McMullin, Philip Beer, et al.. (2012). Guideline for the diagnosis and management of myelofibrosis. British Journal of Haematology. 158(4). 453–471. 71 indexed citations
14.
Wickremasinghe, R. Gitendra, A. G. Prentice, Jonathan C. Strefford, et al.. (2012). Phenethyl Isothiocyanate (PEITC) Regulates Autophagy in Chronic Lymphocytic Leukemia.. Blood. 120(21). 2906–2906. 1 indexed citations
15.
Ernst, Thomas, Andrew Chase, Joannah Score, et al.. (2010). Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders. Nature Genetics. 42(8). 722–726. 807 indexed citations breakdown →
16.
Rayner, Sandra, Andrew Duncombe, M. Keefe, Jeffrey Theaker, & R M Manners. (2008). Necrobiotic Xanthogranuloma Occurring in an Eyelid Scar. Orbit. 27(3). 191–194. 16 indexed citations
18.
Sweetenham, John, et al.. (2000). Automated Immature Reticulocyte Counts Are Early Markers of Engraftment Following Autologous PBSC Transplantation in Patients with Lymphoma. Journal of Hematotherapy & Stem Cell Research. 9(2). 219–223. 13 indexed citations
19.
Duncombe, Andrew. (1997). ABC of clinical haematology: Bone marrow and stem cell transplantation. BMJ. 314(7088). 1179–1179. 23 indexed citations
20.
Heslop, Helen E., Andrew Duncombe, Joyce E. Reittie, et al.. (1991). Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation. British Journal of Haematology. 77(2). 237–244. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026